Literature DB >> 16503410

Movement disorders in Latin America.

André R Troiano1, Federico E Micheli, Fernando Alarcón, Hélio A G Teive.   

Abstract

The authors review some particularities of movement disorders (MDs) in the ethnically diverse population of Latin America. Although idiopathic diseases are evenly prevalent, access to treatment encounters difficulties that are worth discussing. Infectious-parasitic diseases observed throughout the continent occasionally present as MDs, and will be individually reviewed. Inherited MDs with regional foci of increased prevalence, particularly spinocerebellar ataxias, will also be considered. Whereas there is no treatment for genetic disorders, most of the other conditions are preventable or amenable to adequate treatment. Hope for better health standards for the Latin American population lies in profound social and political changes that are still to come.

Entities:  

Mesh:

Year:  2006        PMID: 16503410     DOI: 10.1016/j.parkreldis.2005.08.009

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  3 in total

1.  Factors influencing the clinical expression of intermediate CAG repeat length mutations of the Huntington's disease gene.

Authors:  Peter K Panegyres; Chen-Chun Shu; Huei-Yang Chen; Jane S Paulsen
Journal:  J Neurol       Date:  2014-11-08       Impact factor: 4.849

2.  Prevalence of parkinsonism and Parkinson disease in urban and rural populations from Latin America: A community based study.

Authors:  Jorge J Llibre-Guerra; Matthew Prina; Ana Luisa Sosa; Daisy Acosta; Ivonne Z Jimenez-Velazquez; Mariella Guerra; Aquiles Salas; Juan C Llibre-Guerra; Adolfo Valvuerdi; Geeske Peeters; Ellen Ziegemeier; Isaac Acosta; Caroline Tanner; Jorge Juncos; Juan J Llibre Rodriguez
Journal:  Lancet Reg Health Am       Date:  2022-03

3.  Movement Disorders Among Adult Neurological Outpatients Evaluated over 20 Years in Guayaquil, Ecuador.

Authors:  Oscar H Del Brutto; Victor J Del Brutto
Journal:  Neurol Int       Date:  2013-08-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.